188 related articles for article (PubMed ID: 16568244)
1. The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
Desmet CJ; Peeper DS
Cell Mol Life Sci; 2006 Apr; 63(7-8):755-9. PubMed ID: 16568244
[TBL] [Abstract][Full Text] [Related]
2. K252a induces anoikis-sensitization with suppression of cellular migration in Epstein-Barr virus (EBV)--associated nasopharyngeal carcinoma cells.
Ng YK; Wong EY; Lau CP; Chan JP; Wong SC; Chan AS; Kwan MP; Tsao SW; Tsang CM; Lai PB; Chan AT; Lui VW
Invest New Drugs; 2012 Feb; 30(1):48-58. PubMed ID: 20694504
[TBL] [Abstract][Full Text] [Related]
3. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer.
Tanaka K; Okugawa Y; Toiyama Y; Inoue Y; Saigusa S; Kawamura M; Araki T; Uchida K; Mohri Y; Kusunoki M
PLoS One; 2014; 9(5):e96410. PubMed ID: 24801982
[TBL] [Abstract][Full Text] [Related]
4. Role of Tropomyosin-related kinase B receptor and brain-derived neurotrophic factor in cancer.
Serafim Junior V; Fernandes GMM; Oliveira-Cucolo JG; Pavarino EC; Goloni-Bertollo EM
Cytokine; 2020 Dec; 136():155270. PubMed ID: 32911446
[TBL] [Abstract][Full Text] [Related]
5. Advances in Regulating Tumorigenicity and Metastasis of Cancer Through TrkB Signaling.
Zou W; Hu X; Jiang L
Curr Cancer Drug Targets; 2020; 20(10):779-788. PubMed ID: 32748747
[TBL] [Abstract][Full Text] [Related]
6. Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.
de Moraes JK; Wagner VP; Fonseca FP; Vargas PA; de Farias CB; Roesler R; Martins MD
J Oral Pathol Med; 2018 Mar; 47(3):221-227. PubMed ID: 28650560
[TBL] [Abstract][Full Text] [Related]
7. Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis.
Geiger TR; Peeper DS
Cancer Res; 2007 Jul; 67(13):6221-9. PubMed ID: 17616679
[TBL] [Abstract][Full Text] [Related]
8. BDNF/TrkB signaling as an anti-tumor target.
Roesler R; de Farias CB; Abujamra AL; Brunetto AL; Schwartsmann G
Expert Rev Anticancer Ther; 2011 Oct; 11(10):1473-5. PubMed ID: 21999118
[No Abstract] [Full Text] [Related]
9. Suppression of choriocarcinoma invasion and metastasis following blockade of BDNF/TrkB signaling.
Kawamura K; Kawamura N; Okamoto N; Manabe M
Cancer Med; 2013 Dec; 2(6):849-61. PubMed ID: 24403258
[TBL] [Abstract][Full Text] [Related]
10. Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB.
Douma S; Van Laar T; Zevenhoven J; Meuwissen R; Van Garderen E; Peeper DS
Nature; 2004 Aug; 430(7003):1034-9. PubMed ID: 15329723
[TBL] [Abstract][Full Text] [Related]
11. Activation of BDNF/TrkB pathway promotes prostate cancer progression via induction of epithelial-mesenchymal transition and anoikis resistance.
Li T; Yu Y; Song Y; Li X; Lan D; Zhang P; Xiao Y; Xing Y
FASEB J; 2020 Jul; 34(7):9087-9101. PubMed ID: 32390303
[TBL] [Abstract][Full Text] [Related]
12. The neurotrophic receptor TrkB in anoikis resistance and metastasis: a perspective.
Geiger TR; Peeper DS
Cancer Res; 2005 Aug; 65(16):7033-6. PubMed ID: 16103047
[TBL] [Abstract][Full Text] [Related]
13. Proliferative role of BDNF/TrkB signaling is associated with anoikis resistance in cervical cancer.
Yuan Y; Ye HQ; Ren QC
Oncol Rep; 2018 Aug; 40(2):621-634. PubMed ID: 29989647
[TBL] [Abstract][Full Text] [Related]
14. miR-200c targets a NF-κB up-regulated TrkB/NTF3 autocrine signaling loop to enhance anoikis sensitivity in triple negative breast cancer.
Howe EN; Cochrane DR; Cittelly DM; Richer JK
PLoS One; 2012; 7(11):e49987. PubMed ID: 23185507
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophic receptor TrkB: Is it a predictor of poor prognosis for carcinoma patients?
Han L; Zhang Z; Qin W; Sun W
Med Hypotheses; 2007; 68(2):407-9. PubMed ID: 17008023
[TBL] [Abstract][Full Text] [Related]
16. Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival.
Vanhecke E; Adriaenssens E; Verbeke S; Meignan S; Germain E; Berteaux N; Nurcombe V; Le Bourhis X; Hondermarck H
Clin Cancer Res; 2011 Apr; 17(7):1741-52. PubMed ID: 21350004
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor/tropomyosin-related kinase B signaling pathway contributes to the aggressive behavior of lung squamous cell carcinoma.
Ozono K; Ohishi Y; Onishi H; Nakamura K; Motoshita J; Kato M; Nakanishi R; Nakamura M; Oda Y
Lab Invest; 2017 Nov; 97(11):1332-1342. PubMed ID: 28604655
[TBL] [Abstract][Full Text] [Related]
18. BDNF: An Oncogene or Tumor Suppressor?
Radin DP; Patel P
Anticancer Res; 2017 Aug; 37(8):3983-3990. PubMed ID: 28739680
[TBL] [Abstract][Full Text] [Related]
19. TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
Oyama Y; Nagao S; Na L; Yanai K; Umebayashi M; Nakamura K; Nagai S; Fujimura A; Yamasaki A; Nakayama K; Morisaki T; Onishi H
Anticancer Res; 2021 Aug; 41(8):4047-4052. PubMed ID: 34281873
[TBL] [Abstract][Full Text] [Related]
20. Expression of brain-derived neurotrophic factor and its receptor TrkB is associated with poor prognosis and a malignant phenotype in small cell lung cancer.
Kimura S; Harada T; Ijichi K; Tanaka K; Liu R; Shibahara D; Kawano Y; Otsubo K; Yoneshima Y; Iwama E; Nakanishi Y; Okamoto I
Lung Cancer; 2018 Jun; 120():98-107. PubMed ID: 29748024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
